Financial Perspectives’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$102 Hold
171
﹤0.01% 716
2026
Q1
$227 Hold
171
﹤0.01% 694
2025
Q4
$190 Hold
171
﹤0.01% 695
2025
Q3
$354 Hold
171
﹤0.01% 689
2025
Q2
$335 Hold
171
﹤0.01% 688
2025
Q1
$296 Hold
171
﹤0.01% 690
2024
Q4
$356 Hold
171
﹤0.01% 686
2024
Q3
$508 Hold
171
﹤0.01% 642
2024
Q2
$535 Hold
171
﹤0.01% 632
2024
Q1
$894 Hold
171
﹤0.01% 610
2023
Q4
$424 Hold
171
﹤0.01% 659
2023
Q3
$380 Hold
171
﹤0.01% 668
2023
Q2
$912 Hold
171
﹤0.01% 621
2023
Q1
$1.06K Hold
171
﹤0.01% 618
2022
Q4
$2.21K Hold
171
﹤0.01% 577
2022
Q3
$3.96K Buy
+171
New +$5.19K ﹤0.01% 528

Other funds holding CELU

Financial Perspectives's CELU Position: Q2 2026 in Review

Financial Perspectives held its Celularity (CELU) position steady in Q2 2026 at 171 shares worth $102. The position accounts for ﹤0.01% of the portfolio, ranked #716.

Financial Perspectives first reported a position in CELU in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.96K in Q3 2022. 8 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • Financial Perspectives held 171 shares of Celularity worth $102 as of Q2 2026.
  • Financial Perspectives left its Celularity share count unchanged in Q2 2026.
  • Celularity made up ﹤0.01% of Financial Perspectives's portfolio in Q2 2026, its #716 holding.
  • Financial Perspectives first reported a position in Celularity in Q3 2022 and has held it in 16 quarters since.
  • Financial Perspectives's Celularity position peaked at $3.96K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Financial Perspectives's 13F filing for Q2 2026, filed 24 Jul 2026.